Stocks · News reference
Pennant Gr (NASDAQ:PNTG) raises FY2026 Adj EPS guidance from $1.26-$1.36 to $1.34-$1.41 vs $1.35 analyst estimate. Raises FY2026 sales outlook from $1.134 billion-$1.172 billion to $1.171 billion-$1.190 billion vs
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
The Ensign Group demonstrates strong organic growth momentum with same-facility skilled nursing revenues rising 6.6% year-over-year, driven by higher occupancy at 84.1% and improved clinical outcomes 23% better than state averages. The company's decentralized operating model enables local teams to optimize existing facilities, potentially reducing reliance on acquisitions and supporting more durable long-term earnings growth.
RBC Capital analyst Ben Hendrix maintains Pennant Gr (NASDAQ:PNTG) with a Outperform and raises the price target from $42 to $44.
Wells Fargo analyst Stephen Baxter maintains Pennant Gr (NASDAQ:PNTG) with a Overweight and raises the price target from $45 to $46.